indrofar 50 mg potahované tablety por tbl flm 28x50mg - rizultati

maxitrol augndropar, dreifa

novartis healthcare a/s - neomycinum súlfat; polymyxinum b súlfat; dexamethasonum fosfat - augndropar, dreifa

mydriacyl augndropar, lausn 10 mg/ml

alcon nordic a/s - tropicamidum inn - augndropar, lausn - 10 mg/ml

oculac augndropar, lausn 5 %

alcon nordic a/s - povidonum k25 - augndropar, lausn - 5 %

oculac án rotvarnar augndropar, lausn 5 %

alcon nordic a/s - povidonum k25 - augndropar, lausn - 5 %

opnol augndropar, lausn 1 mg/ml

karo pharma ab* - dexamethasonum fosfat - augndropar, lausn - 1 mg/ml

softacort augndropar, lausn í stakskammtaíláti 3,35 mg/ml

laboratoires thea* - hydrocortisonum natríumfosfat - augndropar, lausn í stakskammtaíláti - 3,35 mg/ml

taflotan augndropar, lausn í stakskammtaíláti 15 míkróg/ml

santen oy* - tafluprostum inn - augndropar, lausn í stakskammtaíláti - 15 míkróg/ml

taflotan sine (taflotan) augndropar, lausn 15 míkróg/ml

santen oy* - tafluprostum inn - augndropar, lausn - 15 míkróg/ml

taptiqom augndropar, lausn í stakskammtaíláti 15 microg/ml + 5 mg/ml

santen oy - tafluprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 15 microg/ml + 5 mg/ml

tobradex augndropar, dreifa

novartis healthcare a/s - dexamethasonum fosfat; tobramycinum inn - augndropar, dreifa